지난 주요뉴스 한국경제TV에서 선정한 지난 주요뉴스 뉴스썸 한국경제TV 웹사이트에서 접속자들이 많이 본 뉴스 한국경제TV 기사만 onoff
-
[PRNewswire] Merck Announces Out-Licensing Agreement for Phase II-ready 2020-10-06 21:25:23
Novartis - Anti-ADAMTS5 Nanobody(R) program is Phase II-ready with novel MoA which could protect against cartilage damage and reduce joint pain - Merck receives upfront payment of € 50 million with the potential of receiving a further € 400 million related to delivering on certain development and...
- 뉴스 > 정치·사회·국제
- 바로가기
-
[PRNewswire] Genome & Company receives FDA IND clearance for GEN-001, its 2020-04-20 19:24:28
& Company receives FDA IND clearance for GEN-001, its first anti-cancer microbiome therapeutic -- Asia's first company to sponsor clinical trial of combination therapy of anti-cancer microbiome and anti-PD1/anti-PD-L1 drug -- Enables to initiate Phase 1/1b clinical trial on combinational therapy...
- 뉴스 > 정치·사회·국제
- 바로가기
-
[PRNewswire] 머크, 크리스퍼 유전자 편집 방식에 대한 최초의 미국 특허를 획득 2019-02-20 09:59:45
- https://mma.prnewswire.com/media/822751/Merck_CRISPR_Patent_Graphic.jpg Merck has been granted 13 CRISPR-related patents worldwide. 출처: 머크 Merck Receives First U.S. Patent for Improved CRISPR Genome-Editing Method -- Proxy-CRISPR technology provides solution to improve genome editing and...
- 뉴스 > 정치·사회·국제
- 바로가기
-
[ 분야별 송고기사 LIST ]-외신 2018-07-27 08:00:04
장기금리, '금융완화정책 변경' 기대에 1년만에 0.1%로 상승 180726-0857 외신-012616:03 [PRNewswire] Merck Receives Recommendation for Approval in 21 EU Countries 180726-0871 외신-012716:07 中 핀둬둬, 나스닥 상장…'바링허우' 황정, 부호서열 16위에 180726-0878 외신-012916:12 美캘리포니아서...
- 뉴스 >
- 바로가기
-
[PRNewswire] Merck Receives Recommendation for Approval in 21 EU Countries 2018-07-26 16:03:37
[PRNewswire] Merck Receives Recommendation for Approval in 21 EU Countries for the New Formulation of Euthyrox(R) * Not intended for UK- or US-based media -- German Federal Institute for Drugs and Medical Devices (BfArM) recommends new formulation of Euthyrox(R) for approval in 21 EU countries --...
- 뉴스 > 정치·사회·국제
- 바로가기
-
[PRNewswire] 머크, 중국에서 크리스퍼(CRISPR)기술에 대한 특허 승인 2018-04-24 10:03:58
- https://mma.prnewswire.com/media/678564/Merck_CRISPR_China.jpg MilliporeSigma has received yet another patent for its CRISPR technology, this time in China. 출처: 머크(Merck) Merck Receives Patent for CRISPR Technology in China - Patent in China covers integration of an external DNA sequence into...
- 뉴스 > 정치·사회·국제
- 바로가기
-
[ 분야별 송고기사 LIST ]-외신 2018-03-28 15:00:07
외신-0065 09:51 김정은 "한반도정세 좋은 방향 발전…유훈 따라 비핵화 주력" 180328-0288 외신-0066 09:52 [PRNewswire] Merck Receives Fast-Track Designation for Tepotinib in Non-Small 180328-0293 외신-0067 09:55 NYT "북 영변 새 원자로 포착…북미정상회담 핵심 의제될 듯" 180328-0297 외신-0068 09:57...
- 뉴스 >
- 바로가기
-
[PRNewswire] Merck Receives Fast-Track Designation for Tepotinib in Non-Small 2018-03-28 09:52:06
[PRNewswire] Merck Receives Fast-Track Designation for Tepotinib in Non-Small Cell Lung Cancer in Japan - Not intended for UK- or US-based media -- Japanese Ministry of Health, Labour and Welfare Grants SAKIGAKE designation for tepotinib, Merck's investigational highly selective c-Met receptor...
- 뉴스 > 정치·사회·국제
- 바로가기
-
[ 분야별 송고기사 LIST ]-외신 2017-11-14 15:00:05
존슨앤드존슨이노베이션, 디지털뷰티퀵파이어대회 개최 171114-0272 외신-0063 09:45 [PRNewswire] Merck Receives FDA Approval for New GONAL-f(R) Prefilled Pen 171114-0277 외신-0064 09:48 빌 게이츠, 알츠하이머 치료제 개발에 5천만달러 기부 171114-0280 외신-0065 09:49 로스 美상무 "日·아시아가 미국 보다 더...
- 뉴스 >
- 바로가기
-
[PRNewswire] Merck Receives FDA Approval for New GONAL-f(R) Prefilled Pen 2017-11-14 09:45:00
[PRNewswire] Merck Receives FDA Approval for New GONAL-f(R) Prefilled Pen -- New pen is easy-to-learn and easy-to-use, supporting the one in six couples affected by infertility in the U.S.[1] -- Insights of patients, nurses and doctors helped to evolve the product [편집자 주] 본고는 자료...
- 뉴스 > 정치·사회·국제
- 바로가기
